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ABSTRACT
To monitor the evolving molecular epidemiology and genetic diversity of HIV in a country where many dis-
tinct strains cocirculate, we performed genetic analyses on sequences from 75 HIV-1-infected Cameroonians:
74 were group M and 1 was group O. Of the group M sequences, 74 were classified into the following env
gp41 subtypes or recombinant forms: CRF02 (n  54), CRF09 (n  2), CRF13 (n  2), A (n  5), CRF11
(n  4), CRF06 (n  1), G (n  2), F2 (n  2), and E (n  1, CRF01), and 1 was a JG recombinant. Com-
parison of phylogenies for 70 matched gp41 and protease sequences showed inconsistent classifications for 18
(26%) strains. Our data show that recombination is rampant in Cameroon with recombinant viruses contin-
uing to recombine, adding to the complexity of circulating HIV strains. This expanding genetic diversity raises
public health concerns for the ability of diagnostic assays to detect these unique HIV mosaic variants and for
the development of broadly effective HIV vaccines.
HIV-1 STRAINS FROM THE WEST-CENTRAL African country ofCameroon show remarkable genetic diversity. Cameroon
is the only country where all three groups of HIV-1, M, N, and
O cocirculate.1–3 Almost all the known HIV subtypes and many
recombinants, including circulating recombinant forms (CRFs)
CRF01, CRF02, CRF04, CRF06, CRF09, CRF11, CRF13, and
numerous unique recombinants, have been described.4–8 Even
recombination between HIV-1 group O and M strains has been
documented in Cameroon.9,10 It is well established that CRF02-
AG and recombinants containing portions of the CRF02 ge-
nome are the most prevalent strains in Cameroon.4–6,11 Con-
tinued genetic characterization of HIV-1 variants in this region,
where multiple subtypes, CRFs, and unique recombinant forms
(URFs) cocirculate, is important for global public health issues
related to this diversity. For example, these complex recombi-
nant viruses raise concern about whether any of these divergent
strains might be missed by current diagnostic assays, as well as
those assays currently under development.
Between September and November 1999, blood specimens
were collected from 75 HIV-1-seropositive, antiretroviral drug-
naive individuals, who routinely attended the tuberculosis (TB)
and sexually transmitted infections (STIs) clinics in the seaport
city of Douala and the capital city of Yaoundé, Cameroon.
Blood specimens were screened for HIV using the rapid Ab-
bott Determine HIV-1/2 assay (Abbott Laboratories, Abbott
Park, IL) and two enzyme immunoassays, Genscreen HIV1/2
Version 2 (Pasteur Diagnostics, Paris, France) and AXSYM
HIV1/2 gO (Abbott norge as, Oslo, Norway). Results from re-
active specimens were confirmed by a Western blot test, HIV
Blot 2.2 (Genelabs Diagnostics, Singapore).12 Peripheral blood
mononuclear cells (PBMCs) were isolated from blood samples
by Ficoll-Hypaque gradient density, pelleted, and stored at
20°C. All individuals provided informed consent, although
samples used in this study were unlinked to patient identifiers.
Viral DNA was extracted from PBMCs using the GFX TM
Genomic blood DNA purification kit (Amersham Pharmacia
Biotech AB, Uppsala, Sweden) or the QIAamp DNA Mini Kit
(QIAGEN Inc, Valencia, CA) according to the manufacturer’s in-
structions. The env gp41 primary gp40F1-forward/gp41R1-re-
verse and nested gp46F2/gp48R2 polymerase chain reaction
(PCR) primers, respectively, were used for amplification of a 445-
bp fragment.13 Nested PCR amplification of the entire protease
(PR) gene with outside primers DP10-forward/DP11-reverse and
inside primers DP16-forward/DP17-reverse was performed as pre-
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TABLE 1. SOCIODEMOGRAPHIC AND GENOTYPIC CHARACTERISTICS OF HIV-1-INFECTED PATIENTS FROM CAMEROON
HIV genetic subtype
Sample ID Clinic City Age Sex gp41 PR
99CM001 STI Yde 25 M CRF02_AG CRF02_AG
99CM007 STI Yde 28 F CRF02_AG CRF02_AG
99CM014 STI Yde 26 F CRF02_AG CRF02_AG
99CM016 STI Yde 28 F CRF02_AG CRF02_AG
99CM026 STI Yde 24 F CRF06_px U
99CM030 TB Yde 27 F CRF02_AG CRF02_AG
99CM031 TB Yde 40 M CRF02_AG U
99CM036 STI Yde 28 M CRF02_AG ND
99CM038 STI Yde 28 M G G
99CM057 TB Yde 40 F CRF02_AG CRF02_AG
99CM060 TB Yde 35 M CRF02_AG CRF02_AG
99CM068 STI Yde 40 M CRF02_AG CRF02_AG
99CM069 STI Yde 27 M CRF02_AG CRF02_AG
99CM072 TB Yde 45 M CRF02_AG F2
99CM074 STI Yde 20 F CRF02_AG CRF02_AG
99CM076 STI Yde 37 M CRF02_AG CRF02_AG
99CM079 STI Yde 25 F CRF11_cpx CRF02_AG
99CM081 STI Yde 27 M O O
99CM082 STI Yde 52 F CRF02_AG CRF02_AG
99CM090 TB Yde 40 M CRF09_cpx CRF02_AG
99CM091 TB Yde 37 F CRF11_cpx CRF02_AG
99CM092 TB Yde 62 F CRF02_AG CRF02_AG
99CM107 STI Yde 26 F CRF02_AG CRF02_AG
99CM109 STI Yde 24 F CRF02_AG CRF02_AG
99CM113 TB Yde 37 F CRF02_AG CRF02_AG
99CM115 TB Yde 38 M CRF13_cpx CRF02_AG
99CM124 TB Yde 34 M CRF02_AG CRF02_AG
99CM126 STI Yde 23 F CRF02_AG CRF02_AG
99CM139 STI Yde 30 M CRF02_AG CRF02_AG
99CM143 STI Yde 24 F CRF02_AG CRF02_AG
99CM148 STI Yde 28 M A ND
99CM149 STI Yde 30 F CRF02_AG CRF02_AG
99CM171 STI Yde 39 F CRF02_AG ND
99CM189 STI Yde 32 M CRF02_AG CRF02_AG
99CM191 STI Yde 28 M CRF02_AG CRF02_AG
99CM197 STI Yde 32 M CRF02_AG CRF02_AG
99CM203 STI Yde 38 M CRF02_AG CRF02_AG
99CM212 STI Yde 33 M CRF13_cpx CRF02_AG
99CM213 STI Yde 33 M F2 F2
99CM221 TB Yde NA F CRF02_AG CRF02_AG
99CM224 STI Yde 27 F CRF01_AE CRF01_AE
99CM225 STI Yde 24 F CRF09_cpx CRF02_AG
99CM227 STI Yde 39 M CRF02_AG CRF02_AG
99CM228 STI Yde 60 M CRF02_AG CRF02_AG
99CM229 STI Yde 44 F CRF02_AG CRF02_AG
99CM247 STI Yde 27 M CRF02_AG CRF02_AG
99CM249 STI Yde 29 F CRF02_AG CRF02_AG
99CM251 STI Yde 22 F CRF02_AG CRF02_AG
99CM258 STI Yde 30 F CRF02_AG CRF02_AG
99CM259 STI Yde 53 F A CRF02_AG
99CM261 STI Yde 21 M F2 CRF11_cpx
99CM275 TB Dla 35 M CRF02_AG CRF02_AG
99CM277 TB Dla 48 F CRF02_AG CRF02_AG
99CM279 TB Dla 29 M A CRF02_AG
99CM284 TB Dla 38 M CRF02_AG CRF02_AG
99CM289 TB Dla 36 F CRF02_AG CRF02_AG
99CM290 TB Dla 31 M CRF02_AG U
99CM311 STI Yde 30 M CRF02_AG CRF02_AG
99CM315 STI Yde 39 F A CRF02_AG
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viously described.14 The PCR amplification was performed with
the Platinum Taq DNA Polymerase High Fidelity PCR system ac-
cording to the manufacturer’s instructions (Life Technology,
Bethesda, MD). After purification (Qiagen, Valencia, CA), PCR
products were directly sequenced using both forward and reverse
nested PCR primers for HIV-1 gp41 and PR gene regions and re-
solved on an automated DNA sequencer ABI model 377 (Applied
Biosystems, Foster City, CA). The derived nucleotide sequences
were aligned using the Clustal W 1.83 multiple sequence align-
ment program included in the GeneStudio package (http://www.
genestudio.com). Reference strains of groups M, N, and O were
extracted from the Los Alamos databases (http://hiv-web.lanl.gov/
MAP/hivmap.html). Phylogenetic analysis was performed by the
neighbor-joining method, with the nucleotide distance calculated
by Kimura’s two-parameter method included in the Phylip pack-
age version 3.5c, with and without bootstrapping.15 An HIV-2 Rod
sequence was used as an outgroup. To avoid the influence of other
sequences on the bootstrap value, confirmations of subtype as-
signments were performed separately for each sequence. The sta-
bility of the tree topology was tested by pruning, which consists
of removing one sequence from an alignment and rerunning the
phylogenetic analysis. For recombination analysis of DNA se-
quences, SimPlot software was used (SimPlot for Windows;
http://sray.med.som.jhmi.edu/RaySoft/SimPlot); this program cal-
culates and plots the percentage identity of the query sequence
with reference sequences from group M viruses, in a sliding-win-
dow manner along the alignment with optimal step size.
Phylogenetic analysis of 75 env gp41 sequences revealed that
74 clustered with HIV-1 group M (Fig. 1) while one clustered with
group O (data not shown). The majority (85.0%, 63 of 74) of group
M sequences fell within the subtype A clade. Fifty-four (85.7%)
of the 63 subtype A sequences were further classified as CRF02,
2 as CRF13, 1 sequence clustered with a previously identified
unique AG recombinant, CM533928 (Fig. 1), and 2 sequences were
found to be phylogenetically related to CRF09 (data not shown).
Similarly, of seven sequences that clustered within the G clade five
were further characterized: 4 grouped with CRF11-cpx reference
sequences and 1 with CRF06-cpx. From the remaining 4
Cameroonian sequences, 2 were subsubtype F2, 1 was CRF01_AE,
and 1 was unclassifiable (99CM341). Further pruning analysis re-
vealed that the unclassifiable sequence clustered significantly
(80% bootstrap value) either with subtype G if subtype J was
not included in phylogenetic analysis or with subtype J when sub-
type G sequences were absent (data not shown). These results sug-
gested the presence of subtype G and J components in the
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TABLE 1. SOCIODEMOGRAPHIC AND GENOTYPIC CHARACTERISTICS OF HIV-1-INFECTED PATIENTS FROM CAMEROON (CONT’D)
HIV genetic subtype
Sample ID Clinic City Age Sex gp41 PR
99CM316 STI Yde 25 F CRF02_AG CRF02_AG
99CM318 TB Yde 43 M CRF02_AG CRF02_AG
99CM322 STI Yde 33 M CRF02_AG CRF02_AG
99CM324 STI Yde 49 M CRF02_AG CRF02_AG
99CM325 STI Yde 25 F CRF11_cpx CRF11_cpx
99CM334 STI Yde 39 F CRF02_AG U
99CM336 STI Yde NA M AGCM53392 AGCM53392
99CM341 STI Yde 20 F G/J CRF11_cpx
99CM344 STI Yde 32 M CRF02_AG CRF02_AG
99CM360 TB Dla 47 F G CRF02_AG
99CM362 TB Dla 31 M CRF02_AG CRF02_AG
99CM369 TB Dla 33 F CRF02_AG CRF02_AG
99CM377 TB Dla 43 F CRF02_AG CRF02_AG
99CM379 TB Dla NA NA CRF02_AG CRF02_AG
99CM384 TB Dla 27 M CRF02_AG U
99CM386 TB Dla NA NA CRF11_cpx ND
NA, not available; U, unclassified; ND, not done; Yde, Yaounde; Dla, Douala.
FIG. 2. Sliding window bootscan analysis (window 160 bp;
step 30 bp) of the Cameroonian unclassifiable env gp41 se-
quence 99CM341 showing the recombination between subtypes
G and J. The reference sequences were from the following sub-
types: A (strain 92UG037), B (strain HXB2), C (strain ET2220),
D (strain NDK), F1 (strain MP411), F2 (strain MP257), G
(strain DRCBL), H (strain V19910, J (strain SE9173), K (strain
EQTB11C), and potential L (strain 83CD03).
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99CM341 gp41 sequence. Sliding-window bootscan analysis of
this sequence showed clear intersubtype recombination with ele-
ments of subtypes G at the 5 portion and J at the 3 end (Fig. 2).
To estimate the extent of recombination involving CRFs cir-
culating in Cameroon in 1999, we compared the env gp41 phy-
logenies for 70 HIV-1 group M and 1 group O sequences with
the subtype/CRF designations of their PR genes (Table 1). There
was concordance between the two gene regions for the group O
strain, as well as for 74% (52 of 70) of the group M strains as
follows: CRF02 (67.1%, n  47), CRF11 (1.4%, n  1), CRF01
(1.4%), cm53392 (1.4%), G (1.4%), and F2 (1.4%). The re-
maining 18 (26%) strains had discordant phylogenies with the
following 10 gp41/PR mosaic structures: CRF02/unclass (n 
4), A/CRF02 (n  3), CRF13/CRF02 (n  2), CRF11/CRF02
(n  2), CRF09/CRF02 (n  2), CRF02/F2 (n  1), G/CRF02
(n  1), F2/CRF11 (n  1), CRF06/unclass (n  1), and inter-
subtype JG/CRF11 (n  1). Overall, parallel analysis of the two
gene regions, PR at 5 and env gp41 at 3-ends, revealed that
only two (2.9%) viruses carried potentially “pure” subtypes (G
and F2). Although CRFs were predominant (76%), almost 25%
were unique recombinants with discordant subtype/CRF desig-
nations between PR and env gene regions. Consistent with
CRF02 being the most predominant strain in Cameroon, most
of the recombinant strains contained a fragment of CRF02.
Overall, our data demonstrated a broad diversity among HIV
sequences from Cameroon, including gp41 and/or PR sequences
from subtypes, CRFs, and URFs. Recombination is ongoing be-
tween these forms of HIV, adding to the increasing diversity in
this region, and raising public health concerns about the abil-
ity of serologic and nucleic acid-based diagnostic assays to de-
tect these complex variants of HIV. Especially since most nu-
cleic acid assays used by blood banks for detecting recent,
“window period” infections have not been thoroughly evalu-
ated on these unique, complex forms of HIV. Studies are on-
going to evaluate Cameroonian serum or plasma samples, with
at least partial subtype characterization, against a large battery
of assays being used to diagnose HIV infections. The increas-
ing genetic diversity of Cameroonian strains also presents a se-
rious challenge for designing and developing broadly effective
HIV-1 vaccines. Finally, the extensive recombination between
circulating strains in Cameroon and other countries where mul-
tiple subtypes, CRFs, and URFs cocirculate continues to create
a dilemma for classification of these complex forms of HIV.
SEQUENCE DATA
The sequences presented in this report have been deposited
in GenBank under accession numbers DQ394108–DQ394177
for protease sequences and AY707001–AY707074 for gp41.
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